The application of glycosphingolipid arrays to autoantibody detection in neuroimmunological disorders

Rinaldi, 2008, Ganglioside antibodies and neuropathies, Curr Opin Neurol, 21, 540, 10.1097/WCO.0b013e32830b84b7 Kaida, 2010, Antibodies to gangliosides and ganglioside complexes in Guillain-Barré syndrome and Fisher syndrome: mini-review, J Neuroimmunol, 223, 5, 10.1016/j.jneuroim.2010.02.001 Kusunoki, 2007, Antibodies against gangliosides and ganglioside complexes in Guillain-Barré syndrome: new aspects of research, Biochim Biophys Acta, 1780, 441, 10.1016/j.bbagen.2007.10.001 Rinaldi, 2013, Update on Guillain-Barré syndrome, J Peripher Nerv Syst, 18, 99, 10.1111/jns5.12020 Willison, 2002, Peripheral neuropathies and anti-glycolipid antibodies, Brain, 125, 2591, 10.1093/brain/awf272 Plomp, 2009, Pathophysiological actions of neuropathy-related anti-ganglioside antibodies at the neuromuscular junction, J Physiol, 587, 3979, 10.1113/jphysiol.2009.171702 Yu, 2011, Structures, biosynthesis, and functions of gangliosides—an overview, J Oleo Sci, 60, 537, 10.5650/jos.60.537 Kolter, 2002, Combinatorial ganglioside biosynthesis, J Biol Chem, 277, 25859, 10.1074/jbc.R200001200 Rinaldi, 2012, Combinatorial glycoarray, Methods Mol Biol, 808, 413, 10.1007/978-1-61779-373-8_28 Kaida, 2013, Immune-mediated neuropathy and anti-glycolipid antibodies, Brain Nerve, 65, 413 Mauri, 2012, Anti-GM1/GD1a complex antibodies in GBS sera specifically recognize the hybrid dimer GM1-GD1a, Glycobiology, 22, 352, 10.1093/glycob/cwr139 Kaida, 2004, Ganglioside complexes as new target antigens in Guillain-Barré syndrome, Ann Neurol, 56, 567, 10.1002/ana.20222 Kaida, 2008, GM1/GalNAc-GD1a complex: a target for pure motor Guillain-Barré syndrome, Neurology, 71, 1683, 10.1212/01.wnl.0000335160.72184.7d Greenshields, 2009, The neuropathic potential of anti-GM1 autoantibodies is regulated by the local glycolipid environment in mice, J Clin Invest, 119, 595, 10.1172/JCI37338 Oyelaran, 2009, Profiling human serum antibodies with a carbohydrate antigen microarray, J Proteome Res, 8, 4301, 10.1021/pr900515y Kaufmann, 2011, Supported lipid bilayer microarrays created by non-contact printing, Lab Chip, 11, 2403, 10.1039/c1lc20073a de Geus, 2013, Glycans from avian influenza virus are recognized by chicken dendritic cells and are targets for the humoral immune response in chicken, Mol Immunol, 56, 452, 10.1016/j.molimm.2013.06.007 Aranzamendi, 2011, Glycan microarray profiling of parasite infection sera identifies the LDNF glycan as a potential antigen for serodiagnosis of trichinellosis, Exp Parasitol, 129, 221, 10.1016/j.exppara.2011.08.015 Harris, 2009, Rewritable glycochips, J Am Chem Soc, 131, 7755, 10.1021/ja901294r Wang, 2007, Photogenerated glycan arrays identify immunogenic sugar moieties of Bacillus anthracis exosporium, Proteomics, 7, 180, 10.1002/pmic.200600478 Disney, 2004, Carbohydrate arrays as tools for the glycomics revolution, Drug Discov Today, 3, 151, 10.1016/S1741-8372(04)02443-0 Godula, 2012, Density variant glycan microarray for evaluating cross-linking of mucin-like glycoconjugates by lectins, J Am Chem Soc, 134, 15732, 10.1021/ja302193u Wehner, 2013, Are multivalent cluster glycosides a means of controlling ligand density of glycoarrays?, Carbohydr Res, 371, 22, 10.1016/j.carres.2013.01.023 Oyelaran, 2009, Microarrays with varying carbohydrate density reveal distinct subpopulations of serum antibodies, J Proteome Res, 8, 3529, 10.1021/pr9002245 Zhang, 2010, Multidimensional glycan arrays for enhanced antibody profiling, Mol Biosyst, 6, 1583, 10.1039/c002259d Narla, 2012, Glyco-macroligand microarray with controlled orientation and glycan density, Lab Chip, 12, 1656, 10.1039/c2lc21224b Carpo, 1999, Marginally improved detection of GM1 antibodies by Covalink ELISA in multifocal motor neuropathy, Neurology, 53, 2206, 10.1212/WNL.53.9.2206 Pestronk, 1997, Multifocal motor neuropathy. Serum IgM anti-GM1 ganglioside antibodies in most patients detected using covalent linkage of GM1 to ELISA plates, Neurology, 49, 1289, 10.1212/WNL.49.5.1289 Townson, 2007, Solid phase immunoadsorption for therapeutic and analytical studies on neuropathy-associated anti-GM1 antibodies, Glycobiology, 17, 294, 10.1093/glycob/cwl074 Willison, 2004, Synthetic disialylgalactose immunoadsorbents deplete anti-GQ1b antibodies from autoimmune neuropathy sera, Brain, 127, 680, 10.1093/brain/awh083 Degroote, 2004, The cell biology of glycosphingolipids, Semin Cell Dev Biol, 15, 375, 10.1016/j.semcdb.2004.03.007 Fantini, 2009, Sphingolipid/cholesterol regulation of neurotransmitter receptor conformation and function, Biochim Biophys Acta, 1788, 2345, 10.1016/j.bbamem.2009.08.016 Pike, 2006, Rafts defined: a report on the Keystone symposium on lipid rafts and cell function, J Lipid Res, 47, 1597, 10.1194/jlr.E600002-JLR200 Fantini, 2010, Molecular insights into amyloid regulation by membrane cholesterol and sphingolipids: common mechanisms in neurodegenerative diseases, Expert Rev Mol Med, 12, e27, 10.1017/S1462399410001602 Fantini, 2013, The driving force of alpha-synuclein insertion and amyloid channel formation in the plasma membrane of neural cells: key role of ganglioside- and cholesterol-binding domains, Adv Exp Med Biol, 991, 15, 10.1007/978-94-007-6331-9_2 Fantini, 2013, Cholesterol accelerates the binding of Alzheimer's beta-amyloid peptide to ganglioside GM1 through a universal hydrogen-bond-dependent sterol tuning of glycolipid conformation, Front Physiol, 4, 120, 10.3389/fphys.2013.00120 Lingwood, 2011, Cholesterol modulates glycolipid conformation and receptor activity, Nat Chem Biol, 7, 260, 10.1038/nchembio.551 Mahfoud, 2010, A major fraction of glycosphingolipids in model and cellular cholesterol-containing membranes is undetectable by their binding proteins, J Biol Chem, 285, 36049, 10.1074/jbc.M110.110189 Yahi, 2010, How cholesterol constrains glycolipid conformation for optimal recognition of Alzheimer's beta amyloid peptide (Abeta1-40), PLoS ONE, 5, e9079, 10.1371/journal.pone.0009079 Bloom, 1991, Physical properties of the fluid lipid-bilayer component of cell membranes: a perspective, Q Rev Biophys, 24, 293, 10.1017/S0033583500003735 Hall, 2010, Role of glycolipids in lipid rafts: a view through atomistic molecular dynamics simulations with galactosylceramide, J Phys Chem B, 114, 7797, 10.1021/jp912175d Hama, 2010, Fatty acid 2-hydroxylation in mammalian sphingolipid biology, Biochim Biophys Acta, 1801, 405, 10.1016/j.bbalip.2009.12.004 Nyholm, 1990, The effect of hydrogen bonds on the conformation of glycosphingolipids. Methylated and unmethylated cerebroside studied by X-ray single crystal analysis and model calculations, Chem Phys Lipids, 52, 1, 10.1016/0009-3084(90)90002-9 Willison, 2005, Ganglioside complexes: new autoantibody targets in Guillain-Barré syndromes, Nat Clin Pract Neurol, 1, 2, 10.1038/ncpneuro0001 Kuwahara, 2013, Clinical features of CIDP with LM1-associated antibodies, J Neurol Neurosurg Psychiatry, 84, 573, 10.1136/jnnp-2012-303440 Rinaldi, 2009, Analysis of lectin binding to glycolipid complexes using combinatorial glycoarrays, Glycobiology, 19, 789, 10.1093/glycob/cwp049 Rinaldi, 2010, Heteromeric glycolipid complexes as modulators of autoantibody and lectin binding, Prog Lipid Res, 49, 87, 10.1016/j.plipres.2009.09.001 Galban-Horcajo, 2013, Antibodies to heteromeric glycolipid complexes in multifocal motor neuropathy, Eur J Neurol, 20, 62, 10.1111/j.1468-1331.2012.03767.x Brennan, 2011, Lipid arrays identify myelin-derived lipids and lipid complexes as prominent targets for oligoclonal band antibodies in multiple sclerosis, J Neuroimmunol, 238, 87, 10.1016/j.jneuroim.2011.08.002 Todeschini, 2008, Ganglioside GM2/GM3 complex affixed on silica nanospheres strongly inhibits cell motility through CD82/cMet-mediated pathway, Proc Natl Acad Sci USA, 105, 1925, 10.1073/pnas.0709619104 Nobile-Orazio, 2013, Sensitivity and predictive value of anti-GM1/galactocerebroside IgM antibodies in multifocal motor neuropathy, J Neurol Neurosurg Psychiatry, 10.1136/jnnp-2013-305755 Pestronk, 1997, Multifocal motor neuropathy: serum IgM binding to a GM1 ganglioside-containing lipid mixture but not to GM1 alone, Neurology, 48, 1104, 10.1212/WNL.48.4.1104 Lloyd, 1992, Cell surface accessibility of individual gangliosides in malignant melanoma cells to antibodies is influenced by the total ganglioside composition of the cells, Cancer Res, 52, 4948 Shichijo, 1986, Inhibitory effects of gangliosides on immune reactions of antibodies to neutral glycolipids in liposomes, Biochim Biophys Acta, 858, 118, 10.1016/0005-2736(86)90297-X Kusunoki, 1999, Monospecific anti-GD1b IgG is required to induce rabbit ataxic neuropathy, Ann Neurol, 45, 400, 10.1002/1531-8249(199903)45:3<400::AID-ANA19>3.0.CO;2-Y Willison, 1999, Inter-laboratory validation of an ELISA for the determination of serum anti-ganglioside antibodies, Eur J Neurol, 6, 71, 10.1046/j.1468-1331.1999.610071.x Cats, 2010, Multifocal motor neuropathy Association of anti-GM1 IgM antibodies with clinical features, Neurology, 75, 1961, 10.1212/WNL.0b013e3181ff94c2 Bech, 1994, ELISA-type titertray assay of IgM anti-GM1 autoantibodies, Clin Chem, 40, 1331, 10.1093/clinchem/40.7.1331 Chabraoui, 1993, Dot-blot immunodetection of antibodies against GM1 and other gangliosides on PVDF-P membranes, J Immunol Methods, 165, 225, 10.1016/0022-1759(93)90348-B Kanter, 2006, Lipid microarrays identify key mediators of autoimmune brain inflammation, Nat Med, 12, 138, 10.1038/nm1344 Gallego, 2010, A systematic screen for protein–lipid interactions in Saccharomyces cerevisiae, Mol Syst Biol, 6, 430, 10.1038/msb.2010.87 Narayan, 2006, Determining selectivity of phosphoinositide-binding domains, Methods, 39, 122, 10.1016/j.ymeth.2006.05.006 Zhang, 2011, Novel 3-dimensional dendrimer platform for glycolipid microarray, Biosens Bioelectron, 28, 355, 10.1016/j.bios.2011.07.044